How Does Inmazeb Work? A Detailed Look at the Triple-Monoclonal Antibody Cocktail
•
3 min read
Inmazeb, the first FDA-approved treatment for Zaire ebolavirus, utilizes a powerful combination of three different monoclonal antibodies. This innovative cocktail was shown in clinical trials to significantly improve patient survival rates, representing a major advancement in the treatment of deadly viral diseases.
